Explore more Articles in

BioTech

Illiquid, Overvalued Assets Spark Market Fears as Buyers Retreat

As "dip buyers" get eviscerated, more dominos fall, and at a tipping point, the herd realizes the tide has reversed and it’s time to...

Medical Groups Sue RFK Jr. For Assault On Science Over Unlawful COVID-19 Vaccine Rollbacks – Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)

In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful alliance of leading medical...

Why Did ZyVersa Therapeutics Stock Shoot Higher On Tuesday? – ZyVersa Therapeutics (NASDAQ:ZVSA)

ZyVersa Therapeutics, Inc. ZVSA stock was trading higher on Tuesday, with a session volume of 160.9 million compared to the average volume of 4.03 million...

US Dollar Gains as Tariff Letters Erode Risk Appetite

Trump letters and August 1 deadline in focus Dollar strengthens as both China and the EU avoid tariff letters Equities are wobbly, while gold confirms lingering...

Altimmune’s Fatty Liver Candidate Faces Differentiation Doubts – Altimmune (NASDAQ:ALT)

On Thursday, Altimmune, Inc. ALT released topline results from the IMPACT Phase 2b trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH).MASH is a severe...

INmune Bio Stock Soars Friday On Alzheimer’s Treatment Hopes – INmune Bio (NASDAQ:INMB)

INmune Bio Inc. INMB stock is trading higher on Friday, with a session volume of 10.26 million compared to the average volume of 519.5K,...

FDA Eases Rules For Bristol Myers’ Cell Therapies For Blood Cancers – Bristol-Myers Squibb (NYSE:BMY)

The U.S. Food and Drug Administration (FDA) approved label updates for Bristol Myers Squibb & Co.’s BMY CAR T cell therapies, Breyanzi (lisocabtagene maraleucel;...

BioCryst Just Ditched Its Europe Business — Here’s Why Investors Are Cheering – BioCryst Pharma (NASDAQ:BCRX)

BioCryst Pharmaceuticals BCRX agrees to sell its European Orladeyo (berotralstat) business to Neopharmed Gentili for up to $264 million.Orladeyo (berotralstat) is the first and...

RFK Jr’s CDC Panel Recommends Merck’s RSV Shot For Infants – Merck & Co (NYSE:MRK)

The U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Merck & Co Inc’s MRK Enflonsia...

EXECUTIVE INTERVIEW: SeaStar CMO And Pediatric Specialist Talk About Promising Therapy To Treat Pediatric AKI – SeaStar Medical Holding (NASDAQ:ICU)

Dr. Kevin Chung, Chief Medical Officer at SeaStar Medical Holding Corporation ICU and Dr. Stuart L. Goldstein, MD, from Cincinnati Children’s Hospital Medical Center,...

- A word from our sponsors -

Most Popular